Iloprost (Ventavis inhaled, BAYQ6256)

DRUG2 trials

Sponsors

Bayer

Conditions

Hypertension, PulmonaryPulmonary Arterial Hypertension

Phase 3

Inhaled Iloprost (Ventavis): Efficacy, Safety, and Pharmacokinetics (PK) Confirmation Study

CompletedNCT01469169

BayerHypertension, Pulmonary

Start: 2012-06-19End: 2016-12-14Updated: 2017-12-07

Unknown Phase

Educational Training Influence in Patients With PAH(Pulmonary Artery Hypertension) on Inhaled Ventavis Treatment Adherence Evaluated Trough INSIGHT System

CompletedNCT01468545

BayerPulmonary Arterial Hypertension

Start: 2011-10-31End: 2014-06-30Updated: 2014-08-29